23andMe is a leading genetic testing and healthcare company that helps consumers access, understand, and benefit from the human genome.
23andMe offers 2 key products to consumers: “Ancestry Test Kits” and “Ancestry + Genetic Health Test Full Suite Kits”. Through these testing products, customers can receive comprehensive risk assessment report on their likelihood of developing genetically influenced diseases, including Parkinson’s, Alzheimer’s, Breast Cancer, Ovarian Cancer, Prostate Cancer, diabetes, and a number of other chronic illnesses. Currently, the Company’s products are offered in 48 countries, its number of genetic profiles have surpassed 10 million profiles, and its issued diabetes reports have reached 70,000 reports.
23andMe maintains strategic co-drug development partnerships with large-scale pharmaceutical companies such as Genentech, Pfizer, and GSK. Additionally, 23andMe is currently developing 13 proprietary candidates within its own drug pipeline.